MedTrace Logo

Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment

NCT04317612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2024-03-01

No results posted yet for this study

Summary

The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.

Conditions

  • Cognitive Impairment, Mild
  • Memory Impairment

Interventions

OTHER

Active berry product

Subjects should consume the active product containing nordic berries daily during the 12 week intervention period.

OTHER

Reference product

Subjects should consume a reference product (isocaloric to active product) daily during the 12 week intervention period.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Berry Lab

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317612 on ClinicalTrials.gov